Skip to content
Acceleron Pharma

Investors/Media

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Aug 3, 2006
BioWorld Today, August 3, 2006
Aug 2, 2006
CAMBRIDGE, MA – August 2, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that it secured a $30 million Series B financing. OrbiMed Advisors, the sole new investor, led the round with participation by all existing institutional investors including Ad...
Jul 17, 2006
BioCentury, July 17, 2006
Jun 21, 2006
CAMBRIDGE, MA – June 21, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics , announced that it has initiated a Phase 1 clinical trial of ACE-011, a novel treatment for bone loss disease, particularly osteoporosis. ACE-011 is the first regenerative therapeutic to enter ...
May 16, 2006
CAMBRIDGE, MA – May 16, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company focused on developing and commercializing therapeutics based on its novel tissue growth factor platform, today announced the appointment of Matthew L. Sherman, M.D. as Senior Vice President and Chief Medical Officer. “Acceleron has built ...
Jun 14, 2004
CAMBRIDGE, MA – June 14, 2004 – Acceleron Pharma announced today the appointment of Glenn Batchelder as president and CEO and a member of the board of directors. Batchelder has been a senior executive at Millennium Pharmaceuticals for the past five years. Acceleron also announced that biopharmaceutical veteran Richard Pops, CEO ...
Feb 13, 2004
BOSTON, MA – February 13, 2004 – Acceleron Pharma, a biopharmaceutical company developing drugs to treat musculoskeletal and metabolic disorders, announced today that it has raised $25 million in its first round of private equity financing. The company has an exceptional team and a set of proprietary approaches that will enable it to...
= add release to Briefcase